Skip to main content
Smart Investors Daily
IN

OTC · INTI

Inhibitor Therapeutics, Inc.

Healthcare · Biotechnology

$0.08

Up+$0.00 (+0.00%)

Updated Aug 17, 2026, 1:18 AM

SID Score

4.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
6.92M
P/E ratio
-2.02
Dividend yield
0.00%
52-week range
— – —
Volume
775
Avg. volume
10.78K

Price performance

INTI price history

1M range · 0 trading sessions · Daily adjusted prices

INTI does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest INTI news

The latest Smart Investors Daily articles mentioning INTI.

INTI research

Overview

Company profile and research snapshot.

Company profile

INHIBITOR THERAPTICS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Zacks Investment Research · May 22, 2024

3 Intriguing Stocks to Watch as Earnings Approach

As beneficiaries of strong business industries, Intuit (INTU), Workday (WDAY), and Booz Allen Hamilton's (BAH) stock all sport a Zacks Rank #2 (Buy) ahead of their quarterly reports this week.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.